SCOPUS 정보 검색 플랫폼

Journal of the American Society of Nephrology

Volumn 22, Issue 6, 2011, Pages 992-993

Trials and tribulations of new agents, novel biomarkers, and retarding renal progression

(2) Levin, Adeera a Beaulieu, Monica C a

a UNIVERSITY OF BRITISH COLUMBIA (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATINE; PIRFENIDONE; TRANSFORMING GROWTH FACTOR BETA;

ALBUMIN BLOOD LEVEL; DIABETIC NEPHROPATHY; DRUG MEGADOSE; DRUG RESPONSE; EDITORIAL; END STAGE LIVER DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; LUNG FIBROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PHENOTYPE; PRIORITY JOURNAL;

EID: 79957721449 PISSN: 10466673 EISSN: 15333450 Source Type: Journal
DOI: 10.1681/ASN.2011040402 Document Type: Editorial

Times cited : (6)

References (10)

1
- 79957670746
- Pirfenidone in diabetic nephropathy
- R.
- Sharma K, Joachim H, Ix JH, Mathew AV, Cho M, Pflueger A, R., DS, Francos B, Sharma S, Falkner B, McGowan TA, Michael Donohue M, Rao SR, Xu R, Fervenza FC, Kopp, JB: Pirfenidone in diabetic nephropathy. J Am Soc Nephrol 22: 1144-1151, 2011
- (2011) J Am Soc Nephrol , vol.22 , pp. 1144-1151
- Sharma, K.¹ Joachim, H.² Ix, J.H.³ Mathew, A.V.⁴ Cho, M.⁵ Pflueger, A.⁶ S, D.⁷ Francos, B.⁸ Sharma, S.⁹ Falkner, B.¹⁰ McGowan, T.A.¹¹ Michael Donohue, M.¹² Rao, S.R.¹³ Xu, R.¹⁴ Fervenza, F.C.¹⁵ Kopp, J.B.¹⁶

2
- 34548834734
- Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis
- Cho ME, Smith DC, Branton MH, Penzak SR, Kopp JB: Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2: 906-913, 2007
- (2007) Clin J Am Soc Nephrol , vol.2 , pp. 906-913
- Cho, M.E.¹ Smith, D.C.² Branton, M.H.³ Penzak, S.R.⁴ Kopp, J.B.⁵

3
- 0036376666
- Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome
- DOI 10.1016/S1096-7192(02)00044-6, PII S1096719202000446
- Gahl WA, Brantly M, Troendle J, Avila NA, Padua A, Montalvo C, Cardona H, Calis KA, Gochuico B: Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab 76: 234-242, 2002 (Pubitemid 35034557)
- (2002) Molecular Genetics and Metabolism , vol.76 , Issue.3 , pp. 234-242
- Gahl, W.A.¹ Brantly, M.² Troendle, J.³ Avila, N.A.⁴ Padua, A.⁵ Montalvo, C.⁶ Cardona, H.⁷ Anton, C.K.⁸ Gochuico, B.⁹

4
- 0029318974
- Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters
- Iyer SN, Wild JS, Schiedt MJ, Hyde DM, Margolin SB, Giri SN: Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters. J Lab Clin Med 125: 779-785, 1995
- (1995) J Lab Clin Med , vol.125 , pp. 779-785
- Iyer, S.N.¹ Wild, J.S.² Schiedt, M.J.³ Hyde, D.M.⁴ Margolin, S.B.⁵ Giri, S.N.⁶

5
- 68149178848
- Pirfenidone is renoprotective in diabetic kidney disease
- Rao SP, Zhu Y, Ravasi T, McGowan TA, Toh I, Dunn SR, Okada S, Shaw MA, Sharma K: Pirfenidone is renoprotective in diabetic kidney disease. J Am Soc Nephrol 20: 1765-1775, 2009
- (2009) J Am Soc Nephrol , vol.20 , pp. 1765-1775
- Rao, S.P.¹ Zhu, Y.² Ravasi, T.³ McGowan, T.A.⁴ Toh, I.⁵ Dunn, S.R.⁶ Okada, S.⁷ Shaw, M.A.⁸ Sharma, K.⁹

6
- 79955630736
- Biological markers of acute kidney injury
- Siew ED, Ware LB, Ikizler, TA: Biological markers of acute kidney injury. J Am Soc Nephrol 22: 810-820, 2011
- (2011) J Am Soc Nephrol , vol.22 , pp. 810-820
- Siew, E.D.¹ Ware, L.B.² Ikizler, T.A.³

7
- 69849113129
- Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria
- Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS, Klein JB: Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol 20: 2065-2074, 2009
- (2009) J Am Soc Nephrol , vol.20 , pp. 2065-2074
- Merchant, M.L.¹ Perkins, B.A.² Boratyn, G.M.³ Ficociello, L.H.⁴ Wilkey, D.W.⁵ Barati, M.T.⁶ Bertram, C.C.⁷ Page, G.P.⁸ Rovin, B.H.⁹ Warram, J.H.¹⁰ Krolewski, A.S.¹¹ Klein, J.B.¹²

8
- 77950601556
- Pathologic classification of diabetic nephropathy
- Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noel LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA: Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21: 556-563, 2010
- (2010) J Am Soc Nephrol , vol.21 , pp. 556-563
- Tervaert, T.W.¹ Mooyaart, A.L.² Amann, K.³ Cohen, A.H.⁴ Cook, H.T.⁵ Drachenberg, C.B.⁶ Ferrario, F.⁷ Fogo, A.B.⁸ Haas, M.⁹ De Heer, E.¹⁰ Joh, K.¹¹ Noel, L.H.¹² Radhakrishnan, J.¹³ Seshan, S.V.¹⁴ Bajema, I.M.¹⁵ Bruijn, J.A.¹⁶

9
- 78149298226
- Mechanisms of tubulointerstitial fibrosis
- Zeisberg M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834, 2010
- (2010) J Am Soc Nephrol , vol.21 , pp. 1819-1834
- Zeisberg, M.¹ Neilson, E.G.²

10
- 77957887259
- The NLRP3 inflammasome promotes renal inflammation and contributes to CKD
- Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, Hemmelgarn BR, Beck PL, Muruve DA: The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 21: 1732-1744, 2010
- (2010) J Am Soc Nephrol , vol.21 , pp. 1732-1744
- Vilaysane, A.¹ Chun, J.² Seamone, M.E.³ Wang, W.⁴ Chin, R.⁵ Hirota, S.⁶ Li, Y.⁷ Clark, S.A.⁸ Tschopp, J.⁹ Trpkov, K.¹⁰ Hemmelgarn, B.R.¹¹ Beck, P.L.¹² Muruve, D.A.¹³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.